Monday, June 22, 2020


Jim Bohannon speaks with CASEY MULLIGAN Ph.D., Professor of Economics at the University of Chicago. Mulligan also served as Chief Economist of the White House Council of Economic Advisers during 2018 and 2019. Mulligan has been a visiting professor at Harvard University, Clemson University, and the Irving B. Harris Graduate School of Public Policy Studies. He served as Chief Economist of the White House Council of Economic Advisers during 2018 and 2019..Casey has received awards and fellowships from the Manhattan Institute, Wolfram Research, the National Tax Association, the Fraser Institute for Public Policy, and various foundations supporting economic research. His research covers capital and labor taxation, the gender wage gap, health economics, regulation, Social Security, voting and the economics of aging. Mulligan has written widely on discrepancies between economic analysis and conventional wisdom. Before You’re Hired!, he wrote Chicago Price Theory (with Jaffe, Minton, and Murphy), Side Effects and Complications, The Redistribution Recession, and Parental Priorities and Economic Inequality. He has also written numerous op-eds and blog entries for the New York Times, the Wall Street Journal, the New York Post, the Chicago Tribune,, and more. Follow @caseybmulligan on Twitter.

His book:


by Casey B Mulligan  (Author)

Publisher: Republic Book Publishers (September 3, 2020) 

Donald J. Trump had essentially zero experience running for office and his candidacy for President of the United States was opposed by many in both parties that dominate American politics. Nevertheless, in 2016 the American people told him “You’re hired!”. As an insider, scholar, and Chief Economist of the President’s Council of Economic Advisers, Casey Mulligan presents riveting first-hand accounts of President Trump’s engagement with policy and politics. The struggle between Trump and a ruling class is skillfully presented by revealing business practices that President Trump is using to dismantle and reshape the Federal administrative state. It proves that today’s populism has some real substance, but also acknowledges Trump’s political incorrectness. You’re Hired! brilliantly details the administration’s successes and failures alongside the scandals, and accurately portrays the approach and capabilities of our President and our government. You will feel like an insider as you learn how Trump handles auto companies, Senator Bernie Sanders, immigration, international aid, the 2016 election, Twitter, and more that the news media has often failed to report or explain. Rigorous evidence is detailed on assertions that the White House staff is in perpetual chaos which is directly attributable to the President. A fascinating comparison of the similarities and differences between Presidents Reagan and Trump is presented along with topics including Obamacare, Putin, the opioid epidemic, and tariffs. This book highlights the great divides created by the President and his “Make America Great Again” (MAGA) supporters being on one side and a small, unelected, and insulated class who have years of experience running, and reporting on the Federal government being on the other side. Anyone wanting to understand, emulate, or oppose President Trump’s “populist” methods will be enthralled by accurate first-hand accounts of how he engages with policy and politics. 


Pandemics have killed at least a half billion people over the past two millennia. Today a new plague, COVID-19, is stalking humanity. But in the age of biotechnology, humanity is no longer defenseless. Biotechnology in the Time of COVID-19 is a collection of stories about the biotechnology industry—its purpose, its people and how it has risen to battle the COVID-19 virus—told by forty-seven leaders of that industry in their own words.

The industry is an ecosystem of scientists, doctors, patients, entrepreneurs, investors, bankers, analysts and reporters, all committed to treating and curing disease. It has been built over the past forty years, producing medical advances at an electrifying rate. As the COVID-19 pandemic emerged, within just two months hundreds of companies had pivoted to apply their technologies to combat the virus.The contributors to this book offer inside views of this seminal industry, historical and personal perspectives, lessons learned, and looks into the future. Diverse as these leaders are, they are united by their conviction that science and medicine will light humanity’s way to greater health and longevity than it has ever known.

The editor royalties and a portion of publisher revenues will be donated to two nonprofits focused on rare disease research: Global Genes ( and The Institute for Life Changing Medicines (

JEREMY M. LEVIN is Chairman and CEO of Ovid Therapeutics Inc (NASDAQ:OVID), a company whose mission is to bring treatment to patients with rare neurological conditions. Dr. Levin is concurrently the chairman of the Biotechnology Innovation Organization (BIO). Prior to founding Ovid, Dr. Levin was president and CEO of Teva Pharmaceutical Industries Ltd., (TLV: TEVA) Before Teva, Dr. Levin was member of the executive committee Bristol-Myers Squibb Company (NYSE: BMY). In that capacity he was the architect of and implemented the String of Pearls Strategy, which transformed Bristol. Dr. Levin joined BMY from Novartis (SWX: NOVN) where he was global head of strategic alliances. He has served on the board of directors of various public and private biopharmaceutical companies and is currently on the board of directors of Lundbeck (OMX: LUN).